| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Adipocytokine signaling pathway 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 2 | Adrenergic signaling in cardiomyocytes 2 genes, 2 drugs (DrugBank), 6 diseases shown |
[2] ADRB1, ADRB2 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| D00378 |
Timolol |
[2] 157, 227 |
| D00603 |
| D08600 |
| 3 | African trypanosomiasis 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 4 | AGE-RAGE signaling pathway in diabetic complications 3 genes, 4 drugs (DrugBank), 25 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 5 | Allograft rejection 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 6 | Alzheimer disease 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 7 | Amoebiasis 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 8 | Amyotrophic lateral sclerosis (ALS) 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 9 | Antifolate resistance 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 10 | Antigen processing and presentation 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 11 | Apoptosis 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 12 | Asthma 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 13 | Bladder cancer 1 gene, 2 drugs (DrugBank), 11 diseases shown |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 14 | Breast cancer 2 genes, 2 drugs (DrugBank), 5 diseases shown |
[2] ESR1, ESR2 |
D00185 |
Estriol |
[2] 13, 227 |
| D01986 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| 15 | C-type lectin receptor signaling pathway 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 16 | Calcium signaling pathway 3 genes, 2 drugs (DrugBank), 6 diseases shown |
[2] ADRB1, ADRB2 |
D00378 |
Timolol |
[2] 157, 227 |
| D00603 |
| D08600 |
| [3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| 17 | cAMP signaling pathway 3 genes, 3 drugs (DrugBank), 13 diseases shown |
[2] ADRB1, ADRB2 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| D00378 |
Timolol |
[2] 157, 227 |
| D00603 |
| D08600 |
| [1] SSTR2 |
D00442 |
Octreotide |
[8] 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| 18 | Cellular senescence 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 19 | cGMP-PKG signaling pathway 3 genes, 2 drugs (DrugBank), 6 diseases shown |
[2] ADRB1, ADRB2 |
D00378 |
Timolol |
[2] 157, 227 |
| D00603 |
| D08600 |
| [3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| 20 | Chagas disease (American trypanosomiasis) 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 21 | Complement and coagulation cascades 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PLG |
D01136 |
Tranexamic acid |
[5] 46, 70, 215, 227, 288 |
| 22 | Cytokine-cytokine receptor interaction 4 genes, 3 drugs (DrugBank), 20 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 23 | Cytosolic DNA-sensing pathway 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 24 | Dilated cardiomyopathy (DCM) 2 genes, 4 drugs (DrugBank), 24 diseases shown |
[1] ADRB1 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| D00378 |
Timolol |
[2] 157, 227 |
| D00603 |
| D08600 |
| [1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 25 | EGFR tyrosine kinase inhibitor resistance 2 genes, 3 drugs (DrugBank), 13 diseases shown |
[1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 26 | Endocrine and other factor-regulated calcium reabsorption 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] ESR1 |
D00185 |
Estriol |
[2] 13, 227 |
| D01986 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| 27 | Endocrine resistance 2 genes, 2 drugs (DrugBank), 5 diseases shown |
[2] ESR1, ESR2 |
D00185 |
Estriol |
[2] 13, 227 |
| D01986 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| 28 | Epstein-Barr virus infection 4 genes, 3 drugs (DrugBank), 20 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 29 | Estrogen signaling pathway 2 genes, 2 drugs (DrugBank), 5 diseases shown |
[2] ESR1, ESR2 |
D00185 |
Estriol |
[2] 13, 227 |
| D01986 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| 30 | Fc epsilon RI signaling pathway 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 31 | Fluid shear stress and atherosclerosis 2 genes, 4 drugs (DrugBank), 25 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 32 | Focal adhesion 1 gene, 2 drugs (DrugBank), 11 diseases shown |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 33 | FoxO signaling pathway 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 34 | Gap junction 1 gene, 2 drugs (DrugBank), 6 diseases shown |
[1] ADRB1 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| D00378 |
Timolol |
[2] 157, 227 |
| D00603 |
| D08600 |
| 35 | Gastric acid secretion 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] SSTR2 |
D00442 |
Octreotide |
[8] 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| 36 | GnRH secretion 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] ESR2 |
D00185 |
Estriol |
[2] 13, 227 |
| D01986 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| 37 | Graft-versus-host disease 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 38 | Growth hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] SSTR2 |
D00442 |
Octreotide |
[8] 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| 39 | Hematopoietic cell lineage 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 40 | Hepatitis B 3 genes, 3 drugs (DrugBank), 20 diseases shown |
[1] IFNAR1 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 41 | Hepatitis C 3 genes, 3 drugs (DrugBank), 20 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 42 | Herpes simplex virus 1 infection 4 genes, 3 drugs (DrugBank), 20 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 43 | HIF-1 signaling pathway 2 genes, 3 drugs (DrugBank), 13 diseases shown |
[1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 44 | Human cytomegalovirus infection 3 genes, 4 drugs (DrugBank), 25 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 45 | Human immunodeficiency virus 1 infection 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 46 | Human papillomavirus infection 4 genes, 5 drugs (DrugBank), 26 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 47 | Human T-cell leukemia virus 1 infection 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 48 | Hypertrophic cardiomyopathy (HCM) 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 49 | IL-17 signaling pathway 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 50 | Inflammatory bowel disease (IBD) 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 51 | Influenza A 5 genes, 4 drugs (DrugBank), 24 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] PLG |
D01136 |
Tranexamic acid |
[5] 46, 70, 215, 227, 288 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 52 | Insulin resistance 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 53 | Intestinal immune network for IgA production 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 54 | JAK-STAT signaling pathway 3 genes, 2 drugs (DrugBank), 7 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 55 | Kaposi sarcoma-associated herpesvirus infection 4 genes, 4 drugs (DrugBank), 14 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 56 | Legionellosis 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 57 | Leishmaniasis 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 58 | Malaria 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 59 | MAPK signaling pathway 2 genes, 4 drugs (DrugBank), 25 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 60 | Measles 3 genes, 2 drugs (DrugBank), 7 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 61 | MicroRNAs in cancer 1 gene, 2 drugs (DrugBank), 11 diseases shown |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 62 | mTOR signaling pathway 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 63 | Natural killer cell mediated cytotoxicity 3 genes, 3 drugs (DrugBank), 20 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 64 | Necroptosis 3 genes, 3 drugs (DrugBank), 20 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 65 | Neuroactive ligand-receptor interaction 5 genes, 4 drugs (DrugBank), 17 diseases shown |
[2] ADRB1, ADRB2 |
D00378 |
Timolol |
[2] 157, 227 |
| D00603 |
| D08600 |
| [3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| [1] PLG |
D01136 |
Tranexamic acid |
[5] 46, 70, 215, 227, 288 |
| [1] SSTR2 |
D00442 |
Octreotide |
[8] 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| 66 | NF-kappa B signaling pathway 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 67 | NOD-like receptor signaling pathway 4 genes, 3 drugs (DrugBank), 20 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 68 | Non-alcoholic fatty liver disease (NAFLD) 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 69 | Osteoclast differentiation 3 genes, 3 drugs (DrugBank), 20 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 70 | Pancreatic cancer 1 gene, 2 drugs (DrugBank), 11 diseases shown |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 71 | Pathogenic Escherichia coli infection 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 72 | Pathways in cancer 6 genes, 6 drugs (DrugBank), 16 diseases shown |
[2] ESR1, ESR2 |
D00185 |
Estriol |
[2] 13, 227 |
| D01986 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| [2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 73 | Pertussis 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 74 | PI3K-Akt signaling pathway 4 genes, 4 drugs (DrugBank), 14 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 75 | Prion diseases 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 76 | Prolactin signaling pathway 2 genes, 2 drugs (DrugBank), 5 diseases shown |
[2] ESR1, ESR2 |
D00185 |
Estriol |
[2] 13, 227 |
| D01986 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| 77 | Proteoglycans in cancer 3 genes, 6 drugs (DrugBank), 26 diseases shown |
[1] ESR1 |
D00185 |
Estriol |
[2] 13, 227 |
| D01986 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| [1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 78 | Rap1 signaling pathway 1 gene, 2 drugs (DrugBank), 11 diseases shown |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 79 | Ras signaling pathway 1 gene, 2 drugs (DrugBank), 11 diseases shown |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 80 | Regulation of lipolysis in adipocytes 3 genes, 2 drugs (DrugBank), 6 diseases shown |
[2] ADRB1, ADRB2 |
D00378 |
Timolol |
[2] 157, 227 |
| D00603 |
| D08600 |
| [3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| 81 | Relaxin signaling pathway 1 gene, 2 drugs (DrugBank), 11 diseases shown |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 82 | Renal cell carcinoma 1 gene, 2 drugs (DrugBank), 11 diseases shown |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 83 | Renin secretion 3 genes, 2 drugs (DrugBank), 6 diseases shown |
[2] ADRB1, ADRB2 |
D00378 |
Timolol |
[2] 157, 227 |
| D00603 |
| D08600 |
| [3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| 84 | Rheumatoid arthritis 3 genes, 4 drugs (DrugBank), 25 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 85 | RIG-I-like receptor signaling pathway 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 86 | Salivary secretion 3 genes, 2 drugs (DrugBank), 6 diseases shown |
[2] ADRB1, ADRB2 |
D00378 |
Timolol |
[2] 157, 227 |
| D00603 |
| D08600 |
| [3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| 87 | Salmonella infection 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 88 | Shigellosis 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 89 | Sphingolipid signaling pathway 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 90 | Staphylococcus aureus infection 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PLG |
D01136 |
Tranexamic acid |
[5] 46, 70, 215, 227, 288 |
| 91 | Systemic lupus erythematosus 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 92 | T cell receptor signaling pathway 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 93 | TGF-beta signaling pathway 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 94 | Th17 cell differentiation 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 95 | Thermogenesis 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| 96 | Thyroid hormone signaling pathway 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] ESR1 |
D00185 |
Estriol |
[2] 13, 227 |
| D01986 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| 97 | TNF signaling pathway 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 98 | Toll-like receptor signaling pathway 4 genes, 3 drugs (DrugBank), 20 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 99 | Toxoplasmosis 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 100 | Transcriptional misregulation in cancer 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 101 | Tuberculosis 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 102 | Type I diabetes mellitus 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 103 | Type II diabetes mellitus 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 104 | VEGF signaling pathway 1 gene, 2 drugs (DrugBank), 11 diseases shown |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 105 | Viral protein interaction with cytokine and cytokine receptor 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 106 | Yersinia infection 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |